Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-lactamase inhibitor combinations

J W Sensakovic1, L G Smith

  • 1Saint Michael's Medical Center, Newark, New Jersey, USA.

The Medical Clinics of North America
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On Five Cases of Hydrocele in the Female.

British medical journal·2010
Same author

Specification of bundle sheath cell fates during maize leaf development: roles of lineage and positional information evaluated through analysis of the tangled1 mutant.

Development (Cambridge, England)·2001
Same author

Infectious complications in asplenic hosts.

Infectious disease clinics of North America·2001
Same author

Plant cell division: building walls in the right places.

Nature reviews. Molecular cell biology·2001
Same author

Baculovirus expression of turkey coronavirus nucleocapsid protein.

Avian diseases·2001
Same author

Oral antibiotic treatment of infectious diseases.

The Medical clinics of North America·2001
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Beta-lactamase inhibitor combinations combat antibiotic resistance by enhancing beta-lactam antibiotics. These novel agents show increased activity against specific bacteria, proving useful in various infections.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Beta-lactamase enzymes confer resistance to beta-lactam antibiotics.
  • Novel therapeutic strategies are needed to overcome antibiotic resistance.
  • Beta-lactamase inhibitor combinations represent a promising approach.

Purpose of the Study:

  • To evaluate the efficacy and spectrum of activity of beta-lactamase inhibitor combinations.
  • To identify clinical situations where these combinations are most beneficial.

Main Methods:

  • Combination therapy involving beta-lactamase inhibitors and beta-lactam antibiotics.
  • Assessment of antimicrobial activity against key pathogens.
  • Clinical utility evaluation in various infection types.

Related Experiment Videos

Main Results:

  • Enhanced activity against methicillin-sensitive Staphylococcus aureus, Haemophilus influenzae, Branhamella catarrhalis, and Bacteroides fragilis.
  • Limited activity against Enterococcus, Pseudomonas, and most gram-negative bacilli, mirroring the antibiotic component.
  • Clinical utility demonstrated in skin/soft tissue, lower respiratory, intra-abdominal, and gynecologic infections.

Conclusions:

  • Beta-lactamase inhibitor combinations offer a valuable tool against specific resistant bacteria.
  • These combinations are particularly effective for certain common bacterial infections.
  • Renal function requires consideration for dosage adjustments in patients with renal insufficiency.